Skip to Content

  • Search

View Additional Section Content

A Randomized, Double-blind, placebo-controlled, Parallel-group Study to Evaluate the Effects of Lon-term Treatment, with BELVIQ on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors.

Principal Investigator(s)
Michael Seidner, M.D.

Clinical Trial Categories

  • Cardiology
Contact
Renee Backer, CCRC at 215-361-7164
or research@greenandseidner.com

Location

  • Green and Seidner Family Practice Associates, PC
    826 North Broad Street
    Lansdale, PA 19446
    Office: 215-855-1054
    Fax: 215-855-3786

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details